Anita Wei is currently the VP for Government Affairs at Danaher China.

Before this role, she was the Senior Director Public Affairs & Communications for BD Greater China and Head of Communications for Novartis Pharma Greater China.

Anita obtained her bachelor’s degree in economics from University of International Business and Economics in Beijing and her Master Degree in Marketing and Communications from University of Sydney.

Anita Wei serves as the Vice Chair of AmCham Shanghai's Healthcare Committee.

Helen Chen, the go-to-person in China healthcare and life sciences, is the Greater China managing partner of L.E.K. Consulting based in Shanghai, and a winner of the prestigious Global Leaders in Consulting for 2019 award from Consulting Magazine. She sat on L.E.K.’s Global Leadership Team, the firm’s governing board, from 2012 to 2016, and served as the head of L.E.K.’s China practice from 2011 to 2018 and Asia life sciences practice from 2015 to 2019. Helen has over 30 years of consulting and industry experience in the U.S. and Asia, and has resided in China since 2000.

Helen is the head of L.E.K.’s China healthcare practice and a board member of L.E.K.’s Asia Pacific Life Sciences Centre of Excellence, supported by Singapore’s Economic Development Board. She has extensive case work and industry experience covering the full biopharmaceutical and medtech value chain, ranging from early research services to post-market product positioning and sales force effectiveness. In China, she has developed commercial strategies for international biopharmas and medtechs, investment thesis for financial investors, business plans for domestic startups and policy analyses for industry associations.

Helen is a frequent speaker and author on the opportunities and issues in the China healthcare and life sciences, and has been quoted by publications including BioCentury, BioWorld, In Vivo, Wall Street Journal, South China Morning Post, Financial Times and Forbes Asia.

Prior to joining L.E.K., Helen was an associate director of finance at Genentech (now Roche) and a sales planner at Abbott Laboratories (now AbbVie). She was on the Board of Pharmaceutical Management Sciences Association from 1995 to 1997.

Helen received her A.B. cum laude in applied mathematics from Harvard University.

Noah is the leader of strategy & business innovation for Medtronic Greater China responsible for localization, commercial expansion and digital health strategies. He has been with Medtronic for 15 years and has been based in Shanghai since 2010 after roles in Los Angeles and Minneapolis. In that time period, he has held various roles in sales & marketing in neuromodulation, diabetes and peripheral vascular and functional leadership in strategy, business development and medical affairs.

A seasoned leader with a proven track record of over 26 years working at leading multinational pharmaceutical companies; 10 years of Country Manager experience at Bristol-Myers Squibb (BMS), Allergan, and Genzyme in China; built Allergan China operation from a small base to the second largest globally;

Led successful launches of numerous brands and established them as market leaders in China, including Opdivo®, Botox®, Alimta®, Gemzar®, Taxol®, Paraplatin® and Juvederm®;

Devoted 15 years to the oncology field as VP & Head of Oncology BU, Eli Lilly China, and as Head of Marketing, Oncology at BMS China;

Started her career as an OB-GYN Doctor and got her M.D. degree from Tongji University School of Medicine in China; received her MBA from the University of Leicester, United Kingdom.

Coaching and mentoring next generation leaders, including women leaders. Led CStone join WAG (Women Alliance Group) as one of the 10 cross-sector founding companies. Founder of “WE-NET”(繁瑛会)，a women leadership organization to develop future women leaders.

Steven Su is the founder and CEO of 名医主刀，a digital platform for surgery appointment founded in 2015. Steven is a series entrepreneur. Previously he worked at Goldman Sachs and Google in the US.